E C Richards
Overview
Explore the profile of E C Richards including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
296
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naik P, Richards E, Ahmed S
Br J Oral Maxillofac Surg
. 2020 Nov;
59(2):240-241.
PMID: 33239202
No abstract available.
2.
Trevejo J, Marino M, Philpott N, Josien R, Richards E, Elkon K
Proc Natl Acad Sci U S A
. 2001 Oct;
98(21):12162-7.
PMID: 11593031
Tumor necrosis factor-alpha (TNF-alpha) is well recognized for its role in mediating innate immune responses. However, the mechanisms of TNF-alpha that influence the adaptive immune response to virus infections are...
3.
Ritter G, Cohen L, WILLIAMS Jr C, Richards E, Old L, Welt S
Cancer Res
. 2001 Sep;
61(18):6851-9.
PMID: 11559561
Mouse monoclonal antibody A33 (mAb A33) recognizes a M(r) 43,000 cell surface glycoprotein (designated A33) expressed in human colonic epithelium and colon cancer but absent from most other normal tissues....
4.
Deckert P, Jungbluth A, Montalto N, Clark M, Finn R, WILLIAMS Jr C, et al.
Int J Cancer
. 2000 Jul;
87(3):382-90.
PMID: 10897044
Therapeutic proteins have been conjugated with polyethylene glycol (PEGylation) to reduce immunogenicity and enhance circulating dose. Here we have investigated the effect of PEGylation on immunogenicity, pharmacokinetics, and histologic microdistribution...
5.
Scott A, Geleick D, Rubira M, Clarke K, Nice E, Smyth F, et al.
Cancer Res
. 2000 Jun;
60(12):3254-61.
PMID: 10866319
The Lewis Y (Ley) antigen is a blood group-related antigen that is expressed in a high proportion of epithelial cancers (including breast, colon, ovary, and lung cancer) and is an...
6.
Noguchi Y, Jungbluth A, Richards E, Old L
Proc Natl Acad Sci U S A
. 1996 Oct;
93(21):11798-801.
PMID: 8876217
Interleukin (IL)-12 has strong antitumor activity in transplantable tumor systems in the mouse. The present study was designed to determine whether tumor induction by 3-methylcholanthrene (3-MC), a carcinogenic hydrocarbon, can...
7.
Welt S, Scott A, Divgi C, Kemeny N, Finn R, Daghighian F, et al.
J Clin Oncol
. 1996 Jun;
14(6):1787-97.
PMID: 8656247
Purpose: A phase I/II study was designed to determine the maximum-tolerated dose (MTD) of iodine 125-labeled monoclonal antibody A33 (125I-mAb A33), its limiting organ toxicity, and the uptake and retention...
8.
Noguchi Y, Richards E, Chen Y, Old L
Proc Natl Acad Sci U S A
. 1995 Mar;
92(6):2219-23.
PMID: 7892250
BALB/c murine sarcoma Meth A is known to have three missense point mutations in p53. We previously reported that a nonamer peptide containing the codon 234 mutational product (designated 234CM)...
9.
Welt S, Divgi C, Kemeny N, Finn R, Scott A, Graham M, et al.
J Clin Oncol
. 1994 Aug;
12(8):1561-71.
PMID: 8040668
Purpose: A phase I/II study was designed to determine the maximum-tolerated dose (MTD) of iodine 131-labeled monoclonal antibody (mAb) A33 (131I-mAb A33) administered intravenously, its limiting organ toxicity, and its...
10.
Turino G, Edelman N, Senior R, Richards E, Fishman A
Aspen Emphysema Conf
. 1968 Jan;
11:139-50.
PMID: 5711540
No abstract available.